MedTrace Logo

Intraoperative CO₂ (Carbon Dioxide)

NCT07592468 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-05-20

No results posted yet for this study

Summary

To evaluate whether intraoperative fractionated CO₂ laser treatment of surgical wound edges improves postoperative scar appearance compared with untreated wound edges following Mohs micrographic surgery (MMS).

Conditions

  • Wound Edges

Interventions

DEVICE

CO2 Fractionated Laser

intraoperative fractionated CO₂ laser treatment of surgical wound edges

PROCEDURE

Non CO2 Laser Treatment

Untreated CO2 fractionated laser wound edges

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Stan Tolkachjov, MD · Baylor Health Care System

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-31
Primary Completion
2027-12-31
Completion
2027-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07592468 on ClinicalTrials.gov